Affiliation:
1. Department of Pharmacology, Sree Balaji Medical College and Hospital, CLC works road, Chrompet, Chennai, Tamil Nadu, India.
Abstract
Introduction: Hyperglycaemia and abnormalities in simple carbohydrate, fat and protein metabolism are the characteristic feature of the metabolic disorder, Diabetes Mellitus. Diabetes mellitus treatment is achieved by modifications in diet, sleep pattern, regular physical activity followed by addition of anti-hyperglycemic drugs like metformin if HbA1C levels stays more than 7.0%.Materials and Methods The study period was from April 2019 – September 2019. The total duration of study was 24 weeks. Total 160 patients were screened; among them 100 participants were selected as per the inclusion criteria. Out of 100 patients, only 91 patients have completed the study. Conclusion To conclude DPP-4 inhibitor Teneligliptin 20mg OD exemplifies to be a pertinent add-on to Metformin 500mg BD to enhance the glycaemic control and could be an operative and reliable medication preference in T2DM through decent patient acceptability.
Publisher
Oriental Scientific Publishing Company
Reference13 articles.
1. 1. American Diabetes Association Strategies for improving care. Diabetes Care. 2016; 39 (suppl 1): S6–S12.
2. 2. Deshmukh V, Sathyanarayana S, Menon S, Patil S, Jones R, Uppal S, et al. Safety and efficacy of initial combination of linagliptin and metformin in patients with type 2 diabetes: A subgroup analysis of Indian patients from a randomized, double-blind, placebo-controlled study. Indian J Endoc Metab. 2015; 19: 256- 61.
3. 3. Fujita Y, Inagaki N. Metformin: clinical topics and new mechanisms of action. Diabetology international. 2017 Mar 1;8(1):4-6.
4. 4. Bennett WL, Wilson LM, Bolen S, Maruthur N, Singh S, Chatterjee R, et al. Oral Diabetes Medications for Adults with Type 2 Diabetes: An Update. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
5. 5. Sharma SK, Panneerselvam A, Singh KP, Parmar G, Gadge P, Swami O. Teneligliptin in management of type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2016;9:251-260